Lv1
80 积分 2024-03-13 加入
Artificial intelligence in antibody–drug conjugate development. Trends Pharmacol Sci. 2025 Dec;46(12):1209-1223. doi: 10.1016/j.tips.2025.10.005
9天前
已完结
Novel antibody drug conjugates containing exatecan derivative-based cytotoxic payloads
19天前
已完结
Discovery of Elironrasib (RMC-6291), a Potent and Orally Bioavailable, RAS(ON) G12C-Selective, Covalent Tricomplex Inhibitor for the Treatment of Patients with RAS G12C-Addicted Cancers
19天前
已完结
Senolytic CAR T cells reverse senescence-associated pathologies
1个月前
已完结
The target atlas for antibody-drug conjugates across solid cancers
1个月前
已完结
New payloads drive next-gen antibody–drug conjugates
1个月前
已完结
Advances in the management of metastatic gastric cancer: current strategies and emerging therapeutics
2个月前
已完结
Systematic Evaluation of Maleimide Spacer Impact on Drug-Linker Deconjugation in Antibody-Drug Conjugates Ex Vivo and In Vivo
2个月前
已完结
Homogeneous multi-payload antibody–drug conjugates
3个月前
已完结
Artificial intelligence in antibody–drug conjugate development
3个月前
已完结
皖公网安备34019202002308
